Therefore, microbial prolyl endopeptidases (PEPs, also known as prolyl oligopeptidases) may constitute the therapeutic keys for the treatment of CD since they are especially effective in the hydrolysis of peptide bonds on the carboxyl side of internal proline residues in gluten-derived oligopeptides [12]. This evidence concerns the gene PREP and Cowden disease.